Cargando...

The effect of apatinib in the treatment of metastatic renal cell carcinoma: a case report and review of the literature

The aim of this study was to explore the effect of apatinib in the treatment of metastatic renal cell carcinoma (mRCC) and related adverse events. A case of mRCC was reported which recurred after surgery and roferon treatment. The patient was treated with apatinib at a dose of 500 mg orally, twice d...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int Med Case Rep J
Autores principales: Bi, Jinling, Liu, Haiyuan, Huang, Yong
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5503666/
https://ncbi.nlm.nih.gov/pubmed/28740436
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IMCRJ.S137484
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!